Ventricular Assist Devices - Global Trends

1.METHODOLOGY
Study Reliability and Reporting Limitations
Disclaimers
Quantitative Techniques & Reporting Level
2.INTRODUCTION
Opportunities in VAD Market
Destination Therapy – An Immense Potential Opportunity
Next Generation Devices to Offer Pronounced Scope
Heart Transplantation Scenario
3.COMPETITION
Thoratec is the Clear Leader
Leading Players in the Global VAD Market
Competition Heats Up
Competitive Technologies
4.PRODUCT FACTS
VADs
Reimbursement Scenario
Select First, Second and Third Generation Implantable VADs (2008)
5.CORPORATE DEVELOPMENTS
UPMC Wins Gold Seal of Approval™ to Use VADs in Destination Therapy
E-Wilson Acquires 97% of the MicroMed Cardiovascular’s Outstanding Shares
Thoratec Receives FDA Approval for its HeartMate II LVAS
HeartWare Receives Conditional Approval for its HeartWare LVAS
Abiomed Receives CE Mark for AB5000 Portable Driver
World Heart Enters into Partnership with Abiomed
Ventracor Receives USFDA Approval to Use its VentrAssist Device in Clinical Trials
NewCorTec Launches a New LVAD
WorldHeart Launches New Pediatric VAD
Ventracor Obtains FDA Approval for VentrAssist’s US BTT Trial
MicroMed Cardiovascular Obtains 5-Year CE Mark Extension for DeBakey
Thoratec Submits PMA for HeartMate II Left Ventricular Assist System
Ventracor Receives ‘Commercial Ready’ Grant to Develop VentrAssist LVAD
Terumo Heart Obtains CE Mark for its DuraHeart® LVAS in Europe
Abiomed Acquires Regulatory Approval in Australia for Impella LP 2.5 LVAD
6.MAJOR PLAYERS
Abiomed, Inc. (USA)
Berlin Heart GmbH (Germany)
EvaHeart Medical USA, Inc. (USA)
HeartWare Limited (Australia)
Jarvik Heart, Inc. (USA)
MEDOS Medizentechnik AG (Germany)
MicroMed Cardiovascular, Inc. (USA)
SynCardia Systems, Inc. (USA)
Terumo Heart, Inc. (USA)
Thoratec Corporation (USA)
Ventracor Limited (Australia)
World Heart Corporation (USA)
7.GLOBAL MARKET ANALYTICS
8.THE UNITED STATES
Heart Ailments – The Death Sentence
Huge Waiting Time for Heart Transplant
VADs for Heart Failures
Market Dynamics
High Selling Price
Drug Industry Poses Competition
Lack of Timely and Quick FDA Approvals
Reimbursement
CMS Increases LVAD Coverage for Heart Patients
New Facility Criteria to Hospitals on VAD Implantation for Destination Therapy
Competition
9.EUROPE
Competitive Landscape
Belgium
Reimbursement Scenario
Germany
The United Kingdom
10.REST OF WORLD
Exhibits
Table 1: Percentage Share Breakdown of Heart Transplants by Country/Region in the World – 2008E
Table 2: Percentage Breakdown of Leading Players in the Global VAD and Circulatory Support Market -
Table 3: Implantations in Units by Select Players in the Global VAD Market –
Table 4: Average Selling Prices of Select VADs by Company and Model
Table 5: Global Ventricular Assist Devices Market by Region for the Period 2007-2015 (Sales in US$ Million)
Table 6: Percentage Breakdown of Global Ventricular Assist Devices Market by Region for the Years 2008 & 2009
Table 7: VAD Market in the US: Percentage Breakdown by Indication
Table 8: Ventricular Assist Devices Market by Segment in the US: 2007-2015 (Sales in US$ Million)
Table 9: Ventricular Assist Devices Market by Segment in Europe: 2007-2015 (Sales in US$ Million)
Table 10: Ventricular Assist Devices Market by Segment in Rest of World: 2007-2015 (Sales in US$ Million)
Companies Profiled